153 related articles for article (PubMed ID: 9531009)
1. The comparative biology of latent herpes simplex virus type 1 and type 2 infections: latency-associated transcript promoter activity and expression in vitro and in infected mice.
Lekstrom-Himes JA; Wang K; Pesnicak L; Krause PR; Straus SE
J Neurovirol; 1998 Feb; 4(1):27-37. PubMed ID: 9531009
[TBL] [Abstract][Full Text] [Related]
2. A herpes simplex virus type 1 mutant with a deletion immediately upstream of the LAT locus establishes latency and reactivates from latently infected mice with normal kinetics.
Maggioncalda J; Mehta A; Bagasra O; Fraser NW; Block TM
J Neurovirol; 1996 Aug; 2(4):268-78. PubMed ID: 8799218
[TBL] [Abstract][Full Text] [Related]
3. Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections.
Chen X; Schmidt MC; Goins WF; Glorioso JC
J Virol; 1995 Dec; 69(12):7899-908. PubMed ID: 7494302
[TBL] [Abstract][Full Text] [Related]
4. The 2.2-kilobase latency-associated transcript of herpes simplex virus type 2 does not modulate viral replication, reactivation, or establishment of latency in transgenic mice.
Wang K; Pesnicak L; Guancial E; Krause PR; Straus SE
J Virol; 2001 Sep; 75(17):8166-72. PubMed ID: 11483762
[TBL] [Abstract][Full Text] [Related]
5. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a bidirectional element located downstream from the herpes simplex virus type 1 latency-associated promoter that increases its activity during latency.
Berthomme H; Lokensgard J; Yang L; Margolis T; Feldman LT
J Virol; 2000 Apr; 74(8):3613-22. PubMed ID: 10729137
[TBL] [Abstract][Full Text] [Related]
7. A non-consensus branch point plays an important role in determining the stability of the 2-kb LAT intron during acute and latent infections of herpes simplex virus type-1.
Mukerjee R; Kang W; Suri V; Fraser NW
Virology; 2004 Jul; 324(2):340-9. PubMed ID: 15207620
[TBL] [Abstract][Full Text] [Related]
8. The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks.
Lekstrom-Himes JA; Pesnicak L; Straus SE
J Virol; 1998 Apr; 72(4):2760-4. PubMed ID: 9525595
[TBL] [Abstract][Full Text] [Related]
9. The abundant latency-associated transcripts of herpes simplex virus type 1 are bound to polyribosomes in cultured neuronal cells and during latent infection in mouse trigeminal ganglia.
Goldenberg D; Mador N; Ball MJ; Panet A; Steiner I
J Virol; 1997 Apr; 71(4):2897-904. PubMed ID: 9060647
[TBL] [Abstract][Full Text] [Related]
10. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.
Goins WF; Sternberg LR; Croen KD; Krause PR; Hendricks RL; Fink DJ; Straus SE; Levine M; Glorioso JC
J Virol; 1994 Apr; 68(4):2239-52. PubMed ID: 8139009
[TBL] [Abstract][Full Text] [Related]
11. Genetic studies exposing the splicing events involved in herpes simplex virus type 1 latency-associated transcript production during lytic and latent infection.
Alvira MR; Goins WF; Cohen JB; Glorioso JC
J Virol; 1999 May; 73(5):3866-76. PubMed ID: 10196281
[TBL] [Abstract][Full Text] [Related]
12. HSV-1 LAT Promoter Deletion Viruses Exhibit Strain-Specific and LAT-Dependent Epigenetic Regulation of Latent Viral Genomes in Human Neurons.
Grams TR; Edwards TG; Bloom DC
J Virol; 2023 Feb; 97(2):e0193522. PubMed ID: 36722973
[TBL] [Abstract][Full Text] [Related]
13. The persistent elevated cytokine mRNA levels in trigeminal ganglia of mice latently infected with HSV-1 are not due to the presence of latency associated transcript (LAT) RNAs.
Carr DJ; Halford WP; Veress LA; Noisakran S; Perng GC; Wechsler SL
Virus Res; 1998 Mar; 54(1):1-8. PubMed ID: 9660066
[TBL] [Abstract][Full Text] [Related]
14. A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome.
Thomas SK; Lilley CE; Latchman DS; Coffin RS
J Virol; 2002 Apr; 76(8):4056-67. PubMed ID: 11907244
[TBL] [Abstract][Full Text] [Related]
15. PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant.
Ramakrishnan R; Levine M; Fink DJ
J Virol; 1994 Nov; 68(11):7083-91. PubMed ID: 7933090
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the 5' end of the herpes simplex virus type 2 latency-associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes.
Wang K; Pesnicak L; Straus SE
J Virol; 1997 Oct; 71(10):7903-10. PubMed ID: 9311880
[TBL] [Abstract][Full Text] [Related]
17. Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.
Lachmann RH; Efstathiou S
J Virol; 1997 Apr; 71(4):3197-207. PubMed ID: 9060683
[TBL] [Abstract][Full Text] [Related]
18. An HSV-1 containing the rat beta-glucuronidase cDNA inserted within the LAT gene is less efficient than the parental strain at establishing a transcriptionally active state during latency in neurons.
Deshmane SL; Valyi-Nagy T; Block T; Maggioncalda J; Wolfe JH; Dillner A; Fraser NW
Gene Ther; 1995 May; 2(3):209-17. PubMed ID: 7614252
[TBL] [Abstract][Full Text] [Related]
19. A 437-base-pair deletion at the beginning of the latency-associated transcript promoter significantly reduced adrenergically induced herpes simplex virus type 1 ocular reactivation in latently infected rabbits.
Hill JM; Garza HH; Su YH; Meegalla R; Hanna LA; Loutsch JM; Thompson HW; Varnell ED; Bloom DC; Block TM
J Virol; 1997 Sep; 71(9):6555-9. PubMed ID: 9261376
[TBL] [Abstract][Full Text] [Related]
20. Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 gamma 34.5 mutants in a mouse eye model.
Spivack JG; Fareed MU; Valyi-Nagy T; Nash TC; O'Keefe JS; Gesser RM; McKie EA; MacLean AR; Fraser NW; Brown SM
J Gen Virol; 1995 Feb; 76 ( Pt 2)():321-32. PubMed ID: 7844554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
